02/13/24 "JAK" of All Trades, Master of Atopic Dermatitis?

Dr. James Song, MD, FAAD
Frontier Dermatology


PRESENTATION TITLE:
JAK of all trades, Master of Atopic Dermatitis

PRESENTATION OBJECTIVES:
1. Recognize when one should consider the use of JAK inhibitors in treating atopic dermatitis
2. Appraise safety data for JAK inhibitors and discuss what this means in the context of dermatology
3. Discuss best practices for risk mitigation and improving patient adherence

DISCLOSURES:
• AbbVie (C,S,I)
• Amgen (C,S,I)
• Arcutis (C,S,I)
• BMS (C,S,I)
• Boehringer Ingeheim (C)
• Dermavant (C,S)
• Eli Lilly (C,S)
• Incyte (C,S,I)
• Janssen (C,S,I)
• LEO (C)
• Novartis (C,S)
• Ortho-dermatologics (C,S)
• Pfizer (C,S)
• Sanofi & Regeneron (C,S)
• SUN (C,S,I)
• UCB (C,S)

C: Consultant
S: Promotional Speaker
I: Clinical Investigator